莊士中國(00298.HK)就出售厚富股份已收取代價13.36億元
格隆匯5月14日丨莊士中國(00298.HK)發佈公吿,就莊士中國附屬擬出售厚富全部股份事項,賣方已於香港從買方以現金妥為收取代價約人民幣13.36億元,並已於2021年5月14日根據買賣協議A的條款及條件完成向買方出售銷售股份及轉讓銷售貸款。於完成後,厚富及番禺項目公司已不再為莊士中國集團及莊士機構集團的附屬公司。
此外,中國賣方已於中國從中國買方集團以現金妥為收取中國代價約人民幣1060萬元。據此,中國賣方及中國買方集團將申請更改凱翔的營業執照。買賣協議B將於完成變更凱翔的營業執照後五個營業日內完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.